BioWorld Science

Feb. 21, 2013

View Archived Issues

Inspiration and Ipsen close sale of hemophilia B product candidate

Read More

Kitasato Daiichi Sankyo files for approval of tetravalent combination vaccine in Japan

Read More

Robot-induced depression demonstrates construct validity as an experimental model

Read More

GlaxoSmithKline synthesizes new JAK3 inhibitors

Read More

KBP BioSciences patents new antibacterial agents

Read More

Beta Pharma presents new ALK/c-Met inhibitors

Read More

Pfizer divulges new tyrosine-protein kinase inhibitors

Read More

Researchers at Gerinda Therapeutics disclose novel protein kinase inhibitors

Read More

Thallion Pharmaceuticals and LFB Biotechnologies terminate collaboration

Read More

Treatment begins in AEZS-108 study in triple-negative breast cancer

Read More

Puma reaches SPA agreement for phase III trial in HER2-positive metastatic breast cancer

Read More

CEP-11981 demonstrates activity against urothelial carcinoma in mice

Read More

New Janus kinase inhibitors prepared at Almirall

Read More

NeurOp and Emory collaborate on cognitive and mental health disorders

Read More

New estrogen receptor ligands reported by Karo Bio

Read More

UCB files applications to extend approval for Cimzia in the U.S. and Europe

Read More

Array BioPharma and Genentech patent novel ERK inhibitors

Read More

Dacomitinib proves effective in bladder cancer models

Read More

Phosphagenics plans to advance oxycodone/TPM technology to clinical trials

Read More

Merck & Co. and Samsung Bioepis enter agreement

Read More

ProtAffin obtains promising preclinical data in cystic fibrosis

Read More

Intramuscular formulations of Leunase approved in Japan

Read More

Abraxane approved in Japan for additional indications

Read More

Japanese authorities approve additional formulation and indication for anti-herpes agent

Read More

Chelsea Therapeutics receives FDA guidance regarding resubmission of Northera NDA

Read More